Panic Attack Treatment Market: By Panic Attacks Type (Generalized Anxiety Disorder, Obsessive-Compulsive Disorder (OCD), Others), By Drug (SSRI, SNRI, and BZD), & By Region-Forecast (2016-2021)
[Lowest Price Guaranteed: $5,250]


Related Topics: Drug , GlaxoSmithKline , Pharmaceuticals , Roche , Stress

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Panic
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email bioportfolio97@gmail.com.

Introduction

Panic attacks are associated with sudden surge of overwhelming anxiety and fear. Globally, development of advance technology for treatment of panic attacks, rise in the incidences of panic attacks, owing to stressful life, sedentary lifestyle, and increasing awareness about panic attacks and its negative affect the quality of life. In addition, increase in adoption of panic attack treatment in emerging economies such as China, India and others, will create new opportunities for global panic attack treatment market. However, side effects of medications such as dry mouth, nauseacould, and habit forming nature, and poor diagnosis rate to detect anxiety disorders are the key restraints for global panic attack treatment market.

This report identifies the global panic attack treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global panic attack treatment market.


Geographically North America dominated global panic attack treatment market, owing to rise in incidence of panic attacks, and prevalence of awareness among people related to anxiety disorders. Asia Pacific is projected to have fastest growth, owing to rapidly increasing stress due to changing lifestyle, and modernising healthcare infrastructure in developing nations such as China, and India in this region. Among all the drugs, Selective Serotonin Reuptake Inhibitor (SSRI) has the highest market share in global panic attack treatment market.

This report segments global panic attack treatment market on the basis of panic attacks type, drug, and regional market as follows:

Panic Attack Treatment Market, By Panic Attacks Type: Generalized Anxiety Disorder, Obsessive-Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), Social Anxiety Disorder, and Other Special Phobias

Panic Attack Treatment Market, By Drug: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin Norepinephrine Reuptake Inhibitor (SNRI), and Benzodiazepines (BZD)

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the panic attack treatment market. Some of the major companies’ profiles in detail are as follows:

GlaxoSmithKline Pharmaceuticals Limited

F. Hoffmann-La Roche

Actavis Pharmaceutical Company

Noven Pharmaceuticals, Inc.

Recordati Rare Diseases

Table of Contents
for Panic Attack Treatment Market: By Panic Attacks Type (Generalized Anxiety Disorder, Obsessive-Compulsive Disorder (OCD), Others), By Drug (SSRI, SNRI, and BZD), & By Region-Forecast (2016-2021)

  • 1. Panic Attack Treatment Market – Market Overview

    2. Executive Summary

    3. Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.3. Product Benchmarking

    3.4. End User Profiling

    3.5. Top 5 Financials Analysis

    4. Panic Attack Treatment Market– Market Forces

    4.1. Drivers

    4.1.1. Development of advance technology for treatment of panic attacks

    4.1.2. Rise in the incidences of panic attacks, owing to stressful life, sedentary lifestyle

    4.1.3. Increasing awareness about panic attacks and its negative affect the quality of life

    4.2. Restraints

    4.2.1. Side effects of medications such as dry mouth, nauseacould, and habit forming nature

    4.2.2. Poor diagnosis rate to detect anxiety disorders

    4.3. Opportunities

    4.3.1. Emerging economies

    4.4. Challenges

    4.5. Porter’s Five Forces Analysis

    4.5.1. Bargaining Power of Suppliers

    4.5.2. Bargaining Power of Buyers

    4.5.3. Threat of New Entrants

    4.5.4. Threat of Substitutes

    4.5.5. Degree of Competition

    5. Panic Attack Treatment Market– Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Panic Attack Treatment Market, By Panic Attacks Type

    6.1. Generalized Anxiety Disorder

    6.2. Obsessive-Compulsive Disorder (OCD)

    6.3. Posttraumatic Stress Disorder (PTSD)

    6.4. Social Anxiety Disorder

    6.5. Other Special Phobias

    7. Panic Attack Treatment Market, By Drug

    7.1. Selective Serotonin Reuptake Inhibitor (SSRI)

    7.2. Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

    7.3. Benzodiazepines (BZD)

    8. Panic Attack Treatment Market, By Geography

    8.1. Europe

    8.1.1. Germany

    8.1.2. France

    8.1.3. Italy

    8.1.4. Spain

    8.1.5. Russia

    8.1.6. U.K.

    8.1.7. Rest of Europe

    8.2. Asia Pacific

    8.2.1. China

    8.2.2. India

    8.2.3. Japan

    8.2.4. South Korea

    8.2.5. Rest of Asia-Pacific

    8.3. North America

    8.3.1. U.S.

    8.3.2. Canada

    8.3.3. Mexico

    8.4. Rest of the World (RoW)

    8.4.1. Brazil

    8.4.2. Rest of RoW

    9. Panic Attack Treatment – Market Entropy

    9.1. Expansion

    9.2. Technological Developments

    9.3. Merger & Acquisitions, and Joint Ventures

    9.4. Supply- Contract

    10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

    10.1. GlaxoSmithKline Pharmaceuticals Limited

    10.2. F. Hoffmann-La Roche

    10.3. Actavis Pharmaceutical Company

    10.4. Noven Pharmaceuticals, Inc.

    10.5. Recordati Rare Diseases

    10.6. Shionogi and Company

    10.7. Abbott Laboratories

    10.8. Sumitomo Dainippon Pharma

    10.9. Pfizer,Inc.

    10.10. Bristol-Myers Squibb

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    11. Appendix

    11.1. Abbreviations

    11.2. Sources

    11.3. Research Methodology

    11.4. Bibliography

    11.5. Compilation of Expert Insights

    11.6. Disclaimer

List Of Tables
in Panic Attack Treatment Market: By Panic Attacks Type (Generalized Anxiety Disorder, Obsessive-Compulsive Disorder (OCD), Others), By Drug (SSRI, SNRI, and BZD), & By Region-Forecast (2016-2021)

No

Additional Details

Publisher

Publisher Information

Reference

80292 | HCR 0258

Report Format

PDF

 Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Panic Exit Devices Market Research Report 2020 (Covid-19 Version)
SummaryMarket Segment as follows:By Region Asia-Pacific North America Europe South Ameri...
01 Jul 2020 by HeyReport USD $3,500 More Info
Panic Disorders Global Clinical Trials Review, H1, 2020
Panic Disorders Global Clinical Trials Review, H1, 2020SummaryGlobalData's clinical trial report, “P...
18 May 2020 by Global Data USD $2,500 More Info
Global Panic Bars Market Research Report 2015-2025
SummaryThe global Panic Bars market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The ...
05 Apr 2020 by HeyReport USD $1,800 More Info
Global Panic Exit Devices Market Research (2015-2019) and Future Forecast (2020-2025)
SummaryThe report forecast global Panic Exit Devices market to grow to reach xxx Million USD in 2019...
26 Dec 2019 by 99Strategy USD $3,300 More Info
Global Panic Bars Market Research (2015-2019) and Future Forecast (2020-2025)
SummaryThe report forecast global Panic Bars market to grow to reach xxx Million USD in 2019 with a ...
17 Dec 2019 by 99Strategy USD $3,300 More Info
2019 Panic Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Panic Disorders Clinical Trials Study” provides complete lis...
24 Apr 2019 by VPA Research USD $1,799 More Info
Panic Disorders Global Clinical Trials Review, H1, 2018
Panic Disorders Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, “P...
30 Apr 2018 by Global Data USD $2,500 More Info
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others) - Global Opportu
Depression includes a variety of mental health problems characterized by the absence of a positive e...
01 Jan 2018 by Allied Market Research USD $3,840 More Info
Global and Chinese Panic & Emergency Exit Devices Industry, 2017 Market Research Report
The 'Global and Chinese Panic & Emergency Exit Devices Industry, 2012-2022 Market Research Report' i...
20 Dec 2017 by Prof Research USD $3,000 More Info
Panic Disorders-Pipeline Insights, 2017
DelveInsight’s, “ Panic Disorders-Pipeline Insights, 2017”, report provides in depth insights on the...
30 May 2017 by Delve Insight USD $1,250 More Info

We Stock...